How AI accelerates radiopharmaceutical drug discovery, optimizes personalized dosimetry

A feature News and Perspectives story on technological advances in oncology was published in Journal of Medical Internet ...
News Medical

Machine learning advances drug discovery through generalizable models

The drug development pipeline is a costly and lengthy process. Identifying high-quality "hit" compounds-those with high potency, selectivity, and favorable metabolic properties-at the earliest stages ...
GEN - Genetic Engineering and Biotechnology News

Pharma Races to Scale AI as Billions Flow into Drug Discovery

The infrastructure moment for AI-driven drug discovery continues to accelerate, with billion-dollar investments flowing into ...

Scientists unveil AI that creates never-before-seen molecules to speed up drug discovery

CoCoGraph: A Leap Forward for Molecular Innovation For decades, the discovery of new molecules has often been a slow and ...
Nature

Translational challenges in multi drug discovery: model informed design to enhance efficacy and limit resistance

Drug resistance is a key reason why promising therapies often stop working during development or after they are introduced. In both infections and cancer, treatment puts strong pressure on resistant ...
Phys.org

OpenBind's first data and model release marks a milestone for AI enabled drug discovery

This integrated operation combines automated chemistry, robust binding measurements and high throughput crystallography at Diamond's XChem Fragment Screening facility with an engineered data release ...
Nasdaq

RVTY & Eli Lilly Partner to Expand Access to AI Drug Discovery Models

Revvity, Inc. RVTY recently announced a collaboration with Eli Lilly and Company to make Eli Lilly’s TuneLab predictive models available through the Revvity Signals platform. The partnership expands ...

Mindbeam sets generative AI models to task on drug design, hunting for better pain meds

Enterprise artificial intelligence infrastructure startup Mindbeam AI Inc. today published research showing how generative AI ...
Business Wire

Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY) today announced a collaboration with Eli Lilly and Company (Lilly) that expands access to Lilly’s high-quality predictive models by making ...
Nanowerk

AI drug discovery model surpasses AlphaFold by predicting if drugs work

The GPCRact AI model goes beyond AlphaFold3 by predicting whether drugs functionally activate G-protein-coupled receptors through allosteric signaling. (Nanowerk News) A research team has developed an ...
Nasdaq

Lilly launches TuneLab platform to give biotechnology companies access to AI-enabled drug discovery models built through over $1 billion in research investment

INDIANAPOLIS, Sept. 9, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the launch of Lilly TuneLab, an artificial intelligence and machine learning (AI/ML) platform that ...
Nature

Translational challenges in multi drug discovery: model informed design to enhance efficacy and limit resistance

This Collection supports and amplifies research related to SDG 3: Good Health & Well-Being and SDG 12: Responsible Consumption & Production ...